Jerome Yankowitz is Associate Professor and Director, Division of Maternal-Fetal Medicine and Fetal Diagnosis and Treatment Unit at the University of Iowa Hospitals and Clinics. Dr. Yankowitz is the author Drug Therapy in Pregnancy and has served as Director, Division of Maternal-Fetal Medicine as well as Director, Maternal-Fetal Medicine Fellowship Program since 1998.
SAFE PRESCRIBING PRACTICES IN PREGNANCY AND LACTATION
Article first published online: 31 DEC 2010
2002 American College of Nurse Midwives
Journal of Midwifery & Womens Health
Volume 47, Issue 6, pages 409–421, November-December 2002
How to Cite
Hansen, W. F., Peacock, A. E. and Yankowitz, J. (2002), SAFE PRESCRIBING PRACTICES IN PREGNANCY AND LACTATION. Journal of Midwifery & Womens Health, 47: 409–421. doi: 10.1016/S1526-9523(02)00324-0
- Issue published online: 31 DEC 2010
- Article first published online: 31 DEC 2010
Midwives and other health care providers face a dilemma when a pregnant woman develops a condition that usually is treated with a pharmacologic agent. Understanding of basic teratology associated with drugs as well as the FDA categorization of agents can assist professionals in recognizing which pharmaceuticals should be used or avoided. In addition to reviewing teratology, this article addresses the use of common drugs for the treatment of upper respiratory conditions, minor pain, gastrointestinal problems, psychiatric illnesses, and neurologic disorders. In each category, current evidence is presented pertaining to which agents should be recommended for pregnant women.